Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
Background: Hepatocellular carcinoma (HCC) is a highly aggressive malignant disease, and numerous studies have demonstrated that an inflammatory environment can induce normal cells to transform into cancerous.Methods: We integrated genomic data to comprehensively assess the association between pyrop...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29bfe4ed6b394449b1118446a27d0e99 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:29bfe4ed6b394449b1118446a27d0e99 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:29bfe4ed6b394449b1118446a27d0e992021-11-15T05:10:54ZDevelopment and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma2296-634X10.3389/fcell.2021.713925https://doaj.org/article/29bfe4ed6b394449b1118446a27d0e992021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.713925/fullhttps://doaj.org/toc/2296-634XBackground: Hepatocellular carcinoma (HCC) is a highly aggressive malignant disease, and numerous studies have demonstrated that an inflammatory environment can induce normal cells to transform into cancerous.Methods: We integrated genomic data to comprehensively assess the association between pyroptosis and tumor microenvironment (TME) cell-infiltrating characteristics in HCC, as well as the potential molecular function and clinical significance of lncRNA.Results: The analysis of CNV alteration frequency displayed that CNV changes were common in 33 PRGs, and most were focused on copy number amplification. As a result of lasso regression analysis, nine differentially expressed lncRNAs (AL031985.3, NRAV, OSMR-AS1, AC073611.1, MKLN1-AS, AL137186.2, AL049840.4, MIR4435-2HG, and AL118511.1) were selected as independent prognosis factors of HCC patients. Patients at high risk have poorer survival than those in the low-risk group in training and testing cohorts. A low-risk score was significantly associated with an IC50 of chemotherapeutics such as bortezomib (p < 0.001), but a high-risk score was significantly linked to docetaxel (p < 0.001), implying that signature served as a prospective predictor for chemosensitivity.Conclusion: This work suggests pyroptosis-related lncRNAs features and their potential mechanisms on tumor microenvironment. The exploration may assist in identifying novel biomarkers and assist patients in predicting their prognosis, clinical diagnosis, and management.Zeng-Hong WuZi-Wei LiDong-Liang YangJia LiuFrontiers Media S.A.articlehepatocellular carcinomapyroptosislncRNAsTCGAprognosisBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hepatocellular carcinoma pyroptosis lncRNAs TCGA prognosis Biology (General) QH301-705.5 |
spellingShingle |
hepatocellular carcinoma pyroptosis lncRNAs TCGA prognosis Biology (General) QH301-705.5 Zeng-Hong Wu Zi-Wei Li Dong-Liang Yang Jia Liu Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma |
description |
Background: Hepatocellular carcinoma (HCC) is a highly aggressive malignant disease, and numerous studies have demonstrated that an inflammatory environment can induce normal cells to transform into cancerous.Methods: We integrated genomic data to comprehensively assess the association between pyroptosis and tumor microenvironment (TME) cell-infiltrating characteristics in HCC, as well as the potential molecular function and clinical significance of lncRNA.Results: The analysis of CNV alteration frequency displayed that CNV changes were common in 33 PRGs, and most were focused on copy number amplification. As a result of lasso regression analysis, nine differentially expressed lncRNAs (AL031985.3, NRAV, OSMR-AS1, AC073611.1, MKLN1-AS, AL137186.2, AL049840.4, MIR4435-2HG, and AL118511.1) were selected as independent prognosis factors of HCC patients. Patients at high risk have poorer survival than those in the low-risk group in training and testing cohorts. A low-risk score was significantly associated with an IC50 of chemotherapeutics such as bortezomib (p < 0.001), but a high-risk score was significantly linked to docetaxel (p < 0.001), implying that signature served as a prospective predictor for chemosensitivity.Conclusion: This work suggests pyroptosis-related lncRNAs features and their potential mechanisms on tumor microenvironment. The exploration may assist in identifying novel biomarkers and assist patients in predicting their prognosis, clinical diagnosis, and management. |
format |
article |
author |
Zeng-Hong Wu Zi-Wei Li Dong-Liang Yang Jia Liu |
author_facet |
Zeng-Hong Wu Zi-Wei Li Dong-Liang Yang Jia Liu |
author_sort |
Zeng-Hong Wu |
title |
Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma |
title_short |
Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma |
title_full |
Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma |
title_fullStr |
Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma |
title_full_unstemmed |
Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma |
title_sort |
development and validation of a pyroptosis-related long non-coding rna signature for hepatocellular carcinoma |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/29bfe4ed6b394449b1118446a27d0e99 |
work_keys_str_mv |
AT zenghongwu developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma AT ziweili developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma AT dongliangyang developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma AT jialiu developmentandvalidationofapyroptosisrelatedlongnoncodingrnasignatureforhepatocellularcarcinoma |
_version_ |
1718428797240344576 |